HORIZON PROJECT | TUMOR LN-oC

Advancing Innovation in Cancer Research: ASPHALION's Role in the Tumor-LN-oC Project

Advancing Innovation in Cancer Research: ASPHALION's Role in the Tumor-LN-oC Project
November 29, 2024

This week, ASPHALION experts Enrique Gutierrez and Marta Rayo Lunar have participated in the 42-month follow-up meeting of the Horizon 2020 Tumor-LN-oC project, which was held online.

This EU-funded project is pioneering a groundbreaking approach to cancer research. The project aims to develop and validate a TRL 5 tumor-lymph node-on-chip platform. This cutting-edge technology integrates 3D tissue models with microfluidic chips, connecting surgically removed human primary tumors and lymph node (LN) tissue from the same lung cancer patients. Acting as a “biological twin” for individual patients, this platform enables the study of tumor-LN interactions, opening new possibilities for personalized medicine.

As the regulatory affairs partner, ASPHALION shared insights on the regulatory framework of this transformative technology during the meeting and outlined upcoming plans to further explore its potential.

For more information about the Tumor-LN-oC project, visit the official website: https://tumor-ln-oc.eu/.

Are you working on an EU-funded project? Let’s collaborate! Contact us at [email protected].

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting